The Latest Breaking News from FDA

Earlier this month, the FDA approved Eli Lilly's Zepbound, a drug similar to its diabetes drug Mounjaro but specifically advertised for weight loss.

It’s no secret that the rate cycle, combined with an AI frenzy, greatly helped mega cap stocks this past year, and greatly harmed small cap stocks in need of capital. But, there may have been some throwing out the baby with the bath water activity in small caps that are…

Antiseizure drugs levetiracetam and clobazam can cause a serious hypersensitivity reaction called drug reactions with eosinophilia and systemic symptoms (DRESS), the FDA said.

Shares in Dutch medical device manufacturer Philips plunged Wednesday after the US Food and Drug Administration warned that its new machine to help patients sleep risked overheating.

The pharma industry’s long-term solid outlook is driven by steady demand for drugs due to the rising frequency of chronic conditions and growing geriatric population coupled with rapid technological innovations. Hence, quality pharma stocks, CytomX Therapeutics (CTMX), Eton Pharmaceuticals (ETON), and GSK (GSK), might be solid investments now for potential…

Morning Markets December E-Mini S&P 500 futures (ESZ2 3) are down -0.17%, and Dec Nasdaq 100 E-Mini futures (NQZ2 3) are down -0.20%. Stock index futures this morning are under pressure on negative carryover from a decline in the Euro Stoxx 50 to a 1-week low. European stocks fell back...

Drugmakers shift reliance from China to India, benefiting Indian CDMOs. Western pharma companies are seeking to limit reliance on Chinese contractors, leading to increased interest in Indian CDMOs.

Neptune's Fix, a product sold illegally with claims to improve brain function and treat conditions such as anxiety, depression, pain and opioid use disorder, contains a potentially dangerous substance called tianeptine.

The US reproductive health expert on being sued for $1m, and winning a top prize for her fight for free speech in the public interest